Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma
Completed · Phase 2
Conditions studied: Melanoma, Malignant Metastatic Melanoma
In brief
The primary objectives of this study are: * To explore the antitumor activity of MEDI-522 ± DTIC in patients with metastatic melanoma. * To determine the safety of MEDI-522 ± DTIC in this patient population.
Key facts
- Study ID
- NCT00066196
- Run by
- MedImmune LLC
- People needed
- 110
- Starts
- 2003-08-01
- Expected to finish
- 2007-06-01
- Last updated by the study team
- 2008-01-15
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic Arizona — Scottsdale, Arizona, United States
- Pacific Shores Medical Group — Long Beach, California, United States
- Saint Francis Memorial Hospital — San Francisco, California, United States
- Cancer Institute Medical Group — Santa Monica, California, United States
- Medical Group of North County — Vista, California, United States
- Yale University School of Medicine — New Haven, Connecticut, United States
- University of Miami — Miami, Florida, United States
- Winship Cancer Institute of Emory University — Atlanta, Georgia, United States
- Oncology Specialists, S.C. — Park Ridge, Illinois, United States
- Indiana Oncology Hematology Consultants — Indianapolis, Indiana, United States
- Indiana University Medical Center — Indianapolis, Indiana, United States
- Johns Hopkins University - SKCC at Johns Hopkins — Lutherville, Maryland, United States
- Boston Medical Center — Boston, Massachusetts, United States
- Kansas City Oncology & Hematology Group — Kansas City, Missouri, United States
- The Melanoma Center of St. Louis — St Louis, Missouri, United States
- HemOnc Care, P.C. — Brooklyn, New York, United States
- Memorial Sloan-Kettering Cancer Center — New York, New York, United States
- UNC-Chapel Hill — Chapel Hill, North Carolina, United States
- Blumenthal Cancer Center — Charlotte, North Carolina, United States
- Providence Portland Medical Center — Portland, Oregon, United States
- Thomas Jefferson University — Philadelphia, Pennsylvania, United States
- University of Pittsburgh Cancer Institute — Pittsburgh, Pennsylvania, United States
- Vanderbilt University Medical Center — Nashville, Tennessee, United States
- Discovery Alliance — Houston, Texas, United States
- The University of Texas, MD Anderson Cancer Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.